Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 11 | 2023 | 778 | 3.720 |
Why?
|
Idiopathic Pulmonary Fibrosis | 13 | 2022 | 428 | 3.700 |
Why?
|
Pulmonary Fibrosis | 5 | 2023 | 536 | 1.490 |
Why?
|
Scleroderma, Systemic | 2 | 2020 | 295 | 1.170 |
Why?
|
Molecular Imaging | 4 | 2023 | 849 | 1.140 |
Why?
|
Continuous Positive Airway Pressure | 6 | 2014 | 550 | 0.920 |
Why?
|
Lung | 14 | 2023 | 9739 | 0.800 |
Why?
|
Fibrosis | 8 | 2023 | 1928 | 0.760 |
Why?
|
Sleep Apnea, Obstructive | 5 | 2014 | 1683 | 0.680 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 378 | 0.610 |
Why?
|
Collagen Type I | 1 | 2019 | 571 | 0.580 |
Why?
|
Bronchiolitis Obliterans | 1 | 2016 | 188 | 0.540 |
Why?
|
Autoantibodies | 3 | 2020 | 2008 | 0.530 |
Why?
|
Dyspnea | 3 | 2019 | 1253 | 0.530 |
Why?
|
Organometallic Compounds | 1 | 2018 | 659 | 0.520 |
Why?
|
Gadolinium | 1 | 2018 | 910 | 0.470 |
Why?
|
Sleep Apnea, Central | 1 | 2013 | 79 | 0.470 |
Why?
|
Lysophospholipids | 2 | 2022 | 328 | 0.460 |
Why?
|
Collagen | 1 | 2021 | 2665 | 0.440 |
Why?
|
Masks | 1 | 2013 | 179 | 0.420 |
Why?
|
Pneumonia | 1 | 2023 | 2099 | 0.410 |
Why?
|
Vascular Diseases | 1 | 2018 | 1141 | 0.370 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1512 | 0.370 |
Why?
|
Positron-Emission Tomography | 3 | 2021 | 6270 | 0.330 |
Why?
|
Capillary Permeability | 2 | 2022 | 846 | 0.310 |
Why?
|
Autoantigens | 2 | 2020 | 903 | 0.260 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2022 | 75 | 0.220 |
Why?
|
Lung Neoplasms | 3 | 2023 | 12540 | 0.220 |
Why?
|
Magnetic Resonance Imaging | 6 | 2021 | 34430 | 0.220 |
Why?
|
Models, Biological | 1 | 2019 | 9809 | 0.210 |
Why?
|
Humans | 39 | 2023 | 715818 | 0.190 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2023 | 189 | 0.190 |
Why?
|
Gallium Radioisotopes | 1 | 2019 | 152 | 0.180 |
Why?
|
Research Subjects | 1 | 2021 | 248 | 0.170 |
Why?
|
Ephrin-B2 | 1 | 2017 | 42 | 0.170 |
Why?
|
Critical Care | 2 | 2021 | 2494 | 0.170 |
Why?
|
Receptors, Chemokine | 1 | 2021 | 672 | 0.160 |
Why?
|
Blood Pressure | 2 | 2014 | 8544 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 7 | 2021 | 20357 | 0.160 |
Why?
|
Molecular Probes | 1 | 2018 | 323 | 0.150 |
Why?
|
Lung Diseases | 2 | 2019 | 1905 | 0.150 |
Why?
|
Galectin 3 | 1 | 2018 | 217 | 0.150 |
Why?
|
Sepsis | 2 | 2021 | 2465 | 0.150 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15911 | 0.150 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 4379 | 0.150 |
Why?
|
Myofibroblasts | 1 | 2017 | 204 | 0.140 |
Why?
|
Biopsy | 3 | 2022 | 6737 | 0.140 |
Why?
|
Bronchiectasis | 1 | 2016 | 134 | 0.130 |
Why?
|
Plasma Cells | 1 | 2018 | 602 | 0.130 |
Why?
|
Obesity Hypoventilation Syndrome | 1 | 2014 | 18 | 0.130 |
Why?
|
Fibroblasts | 2 | 2023 | 4228 | 0.130 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1193 | 0.120 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2017 | 607 | 0.120 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1673 | 0.120 |
Why?
|
Shock, Septic | 1 | 2019 | 726 | 0.120 |
Why?
|
Prone Position | 1 | 2014 | 192 | 0.120 |
Why?
|
Breath Tests | 1 | 2014 | 286 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1145 | 0.110 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1897 | 0.110 |
Why?
|
Case-Control Studies | 3 | 2019 | 21795 | 0.110 |
Why?
|
Endothelial Cells | 2 | 2022 | 3374 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 9596 | 0.110 |
Why?
|
Tidal Volume | 1 | 2014 | 489 | 0.110 |
Why?
|
Patient Admission | 1 | 2019 | 1396 | 0.110 |
Why?
|
Critical Illness | 2 | 2021 | 2529 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 977 | 0.100 |
Why?
|
Forced Expiratory Volume | 1 | 2016 | 1750 | 0.100 |
Why?
|
Patient Positioning | 1 | 2014 | 330 | 0.100 |
Why?
|
Artificial Intelligence | 1 | 2022 | 1744 | 0.100 |
Why?
|
Aged | 10 | 2021 | 162468 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2019 | 1489 | 0.100 |
Why?
|
Female | 16 | 2021 | 377229 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1575 | 0.090 |
Why?
|
Male | 16 | 2021 | 350352 | 0.090 |
Why?
|
Antigens, CD | 1 | 2020 | 4152 | 0.090 |
Why?
|
Skin Diseases | 1 | 2017 | 1066 | 0.090 |
Why?
|
Autonomic Nervous System | 1 | 2014 | 676 | 0.090 |
Why?
|
Middle Aged | 11 | 2021 | 214666 | 0.090 |
Why?
|
Contrast Media | 2 | 2020 | 5276 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58326 | 0.080 |
Why?
|
Lung Transplantation | 1 | 2016 | 1163 | 0.080 |
Why?
|
Polysomnography | 1 | 2013 | 1710 | 0.080 |
Why?
|
Retrospective Studies | 5 | 2023 | 72473 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2019 | 3451 | 0.070 |
Why?
|
Prognosis | 2 | 2020 | 29007 | 0.070 |
Why?
|
Bariatric Surgery | 1 | 2014 | 893 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13219 | 0.060 |
Why?
|
Skin | 1 | 2017 | 4297 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9971 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7446 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2014 | 2473 | 0.060 |
Why?
|
Heart Rate | 1 | 2014 | 4096 | 0.060 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 257 | 0.050 |
Why?
|
Bleomycin | 1 | 2022 | 504 | 0.050 |
Why?
|
Hypertrophy | 1 | 2022 | 560 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2017 | 8047 | 0.050 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2019 | 32 | 0.050 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 35 | 0.050 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2021 | 187 | 0.050 |
Why?
|
Therapeutic Equipoise | 1 | 2019 | 30 | 0.050 |
Why?
|
Peroxidase | 1 | 2023 | 629 | 0.050 |
Why?
|
Sphingosine | 1 | 2022 | 311 | 0.050 |
Why?
|
Animals | 6 | 2022 | 169404 | 0.050 |
Why?
|
Exoribonucleases | 1 | 2019 | 87 | 0.040 |
Why?
|
Telomere-Binding Proteins | 1 | 2019 | 96 | 0.040 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2019 | 58 | 0.040 |
Why?
|
Mucin-5B | 1 | 2019 | 137 | 0.040 |
Why?
|
Electroencephalography | 1 | 2013 | 5805 | 0.040 |
Why?
|
Immunosorbent Techniques | 1 | 2018 | 201 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 56228 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 62040 | 0.040 |
Why?
|
Proton Pump Inhibitors | 1 | 2022 | 480 | 0.040 |
Why?
|
Hemoptysis | 1 | 2019 | 153 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39305 | 0.040 |
Why?
|
Sample Size | 1 | 2020 | 823 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4492 | 0.040 |
Why?
|
Adult | 6 | 2021 | 212279 | 0.040 |
Why?
|
Cohort Studies | 1 | 2019 | 40032 | 0.040 |
Why?
|
Heart Failure | 1 | 2019 | 10041 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2018 | 402 | 0.040 |
Why?
|
Exocytosis | 1 | 2017 | 362 | 0.040 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 492 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2021 | 19537 | 0.040 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2019 | 570 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2022 | 1110 | 0.040 |
Why?
|
Sex Distribution | 1 | 2021 | 2371 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2019 | 608 | 0.030 |
Why?
|
Resuscitation | 1 | 2019 | 640 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2018 | 919 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1974 | 0.030 |
Why?
|
Observer Variation | 1 | 2021 | 2676 | 0.030 |
Why?
|
Telomerase | 1 | 2019 | 736 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8270 | 0.030 |
Why?
|
Integrins | 1 | 2018 | 829 | 0.030 |
Why?
|
Pyridones | 1 | 2019 | 692 | 0.030 |
Why?
|
DNA Helicases | 1 | 2019 | 825 | 0.030 |
Why?
|
Sarcoidosis | 1 | 2019 | 524 | 0.030 |
Why?
|
Gene Deletion | 1 | 2022 | 2824 | 0.030 |
Why?
|
Supine Position | 1 | 2014 | 197 | 0.030 |
Why?
|
United States | 1 | 2021 | 67910 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18197 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1181 | 0.030 |
Why?
|
Respiration | 1 | 2020 | 1670 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 9004 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2018 | 1496 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1343 | 0.030 |
Why?
|
Risk Factors | 2 | 2020 | 70879 | 0.030 |
Why?
|
Protein Transport | 1 | 2017 | 2054 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2022 | 22663 | 0.030 |
Why?
|
Artifacts | 1 | 2020 | 1912 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2129 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14902 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2222 | 0.020 |
Why?
|
Indoles | 1 | 2019 | 1842 | 0.020 |
Why?
|
Mice | 3 | 2022 | 80373 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2613 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9849 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3754 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 5101 | 0.020 |
Why?
|
Remission Induction | 1 | 2014 | 2394 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6803 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4918 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 6009 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 51317 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5853 | 0.020 |
Why?
|
Stroke Volume | 1 | 2019 | 4487 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3689 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4029 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15198 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7960 | 0.020 |
Why?
|
Acute Disease | 1 | 2015 | 7142 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16311 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13623 | 0.020 |
Why?
|
Genetic Variation | 1 | 2019 | 6664 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2017 | 15058 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10615 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8890 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19905 | 0.010 |
Why?
|
Obesity | 2 | 2014 | 12248 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8075 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9985 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6386 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 11940 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 2998 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17409 | 0.010 |
Why?
|
Adolescent | 1 | 2014 | 85157 | 0.000 |
Why?
|
Neoplasms | 1 | 2013 | 20528 | 0.000 |
Why?
|
Concepts
(187)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(66)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_